Amsterdam, Netherlands

Dzjemma Sarkisjan

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Rexahn Pharmaceuticals, Inc.. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dzjemma Sarkisjan. Retrieved from https://idiyas.com/inventor/dzjemma-sarkisjan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dzjemma Sarkisjan

Introduction

Dzjemma Sarkisjan is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 2 patents to his name, Sarkisjan's work is recognized for its potential impact on medical science.

Latest Patents

Sarkisjan's latest patents focus on Fluorocyclopentenylcytosine methods of use. The disclosed subject matter provides methods using and kits comprising a compound of formula (I) or a hydrate, a solvate, or a pharmaceutically acceptable salt thereof. Furthermore, it outlines a method of treating one or more symptoms of cancer by administering to a subject in need thereof a compound of formula (I) along with a process for preparing such.

Career Highlights

Dzjemma Sarkisjan is currently associated with Rexahn Pharmaceuticals, Inc., where he continues to innovate and develop new therapeutic methods. His work is pivotal in advancing cancer treatment options and improving patient outcomes.

Collaborations

Sarkisjan has collaborated with esteemed colleagues such as Young Bok Lee and Deog Joong Kim. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

In summary, Dzjemma Sarkisjan's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing medical science for the benefit of patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…